ImageneBio, Inc. (IMA)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for ImageneBio, Inc.. Most notable: 2026-06-26: Filed 8-K disclosing director or officer change; 2026-07-23: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Insider purchase
    SLATTERY JOSEPH P (director) bought $96k of stock
  8. Material 8-K filing
    Filed 8-K disclosing director or officer change
  9. Material 8-K filing
    Filed 8-K disclosing director or officer change
  10. Material 8-K filing
    Filed 8-K disclosing material agreement
  11. Material 8-K filing
    Filed 8-K disclosing director or officer change
  12. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-03-16Yarema KristindirectorA85,4000$0
2025-12-30Butler ErinofficerA22,5000$0
2025-12-24SLATTERY JOSEPH PdirectorP16,0005.99$95,840
2025-07-28Marango JotinofficerF4,63017.16$79,451
2025-07-28Marango JotinofficerA15,776——
2025-07-25Wang Stephen HuidirectorA188,042——
2025-07-25Wang Stephen HuidirectorA12,535——
2025-07-25Wang Stephen HuidirectorA50,144——
2025-07-25Wang Jonathan JiandirectorA143,832——
2025-07-25Wang Jonathan JiandirectorA971,173——
2025-07-25ORBIMED ADVISORS LLCdirectorA83,6112.49$208,191
2025-07-25Bonita David PdirectorM379——
2025-07-25Bonita David PdirectorP83,61129.9$2,499,969
2025-07-25Stampacchia OtellodirectorP267,55629.9$7,999,924
2025-07-25Stampacchia OtellodirectorM379——
2025-07-25Butler ErinofficerA3,051——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings